Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX)
| Market Cap | 9.44M-42.6% |
| Revenue (ttm) | 0 |
| Net Income | -18.76M-54.1% |
| EPS | -14.92+99.0% |
| Shares Out | 2.01M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 24,085 |
| Open | 4.79 |
| Previous Close | 4.72 |
| Day's Range | 4.62 - 4.83 |
| 52-Week Range | 3.25 - 41.80 |
| Beta | 1.66 |
| Analysts | Buy |
| Price Target | 20.00(+325.53%) |
| Earnings Date | Nov 5, 2026 |
Quoin Pharmaceuticals, Ltd. has a live Insider Score.
Scored on 4 qualifying trades from 4 insiders in the last 90 days.
About QNRX
Quoin Pharmaceuticals, Ltd. operates as a specialized pharmaceutical firm, concentrating its efforts on devising therapeutic solutions for rare and orphan medical conditions. Its flagship offering, QRX003, is a topical lotion specifically formulated to address Netherton Syndrome. Furthermore, the company is advancing QRX004 for the management of dystrophic epidermolysis bullosa, alongside QRX006, a prospective therapy for an additional rare dermatological ailment. The organization maintains its operational base in Ashburn, Virginia.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$QNRX stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in QNRX holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by QNRX's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
QNRX Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New QNRX patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to QNRX from public contracts
Source: USAspending.gov
QNRX Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from QNRX’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score